Citron's Left Disputes Valeant Call for SEC Investigation

Andrew Left, founder at Citron Research, reacts to comments from Valeant Pharmaceuticals Chief Executive Officer J. Michael Pearson on a Monday morning conference call and discusses developments in the story since he went public with his accusations about the company's relationship with Philidor. He speaks on "Bloomberg Markets." (Source: Bloomberg) (Source: Bloomberg)

Nafta Talks Seek U.S., Canada, Mexico Trade Reset
50:20 - Talks are set to begin Wednesday on renegotiating the decades-old Nafta trade deal between the United States, Canada, and Mexico. Bloomberg's Kevin Cirilli reports on "Bloomberg Surveillance." (Source: Bloomberg)
  • Trump Says Amazon Is Causing 'Great Damage' to Retailers
  • Strategist Valliere Says Kelly Failed to Curb Trump
  • Nassim Nicholas Taleb Sees Greater Risks Than Nuclear War